Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

Arthritis Research and Therapy

Volumn 14, Issue 5, 2012, Pages

  Lee, Sang Won ^a   Park, Hee Jin ^a   Kim, Beom K ^a   Han, Kwang Hyub ^a   Lee, Soo Kon ^a   Kim, Seung U ^a   Park, Yong Beom ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; GAMMA GLUTAMYLTRANSFERASE; HYDROXYCHLOROQUINE; LEFLUNOMIDE; MELOXICAM; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT; ISOXAZOLE DERIVATIVE;

ADULT; ARTICLE; BLOOD TESTIS BARRIER; BODY MASS; ELASTOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER FUNCTION; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; RHEUMATOID ARTHRITIS; ARTHRITIS, RHEUMATOID; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DOSE RESPONSE; DRUG COMBINATION; ECHOGRAPHY; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RISK FACTOR;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; ISOXAZOLES; LIVER; LIVER CIRRHOSIS; MALE; METHOTREXATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 84867902255     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4075     Document Type: Article

References (26)

1. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001, 344:907-916. 10.1056/NEJM200103223441207, 11259725.
2. Zwerina J, Redlich K, Schett G, Smolen JS. Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann NY Acad Sci 2005, 1051:716-729. 10.1196/annals.1361.116, 16127012.
3. Sfikakis PP. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr Dir Autoimmun 2010, 11:180-210.
4. Paulus HE. The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis. Arthritis Rheum 1990, 33:113-120. 10.1002/art.1780330116, 1967942.
5. Weinblatt ME, Kaplan H, Germain BF, Block S, Solomon SD, Merriman RC, Wolfe F, Wall B, Anderson L, Gall E, Torretti D, Weissman B. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum 1994, 37:1492-1498. 10.1002/art.1780371013, 7945475.
6. Schnabel A, Gross WL. Low-dose methotrexate in rheumatic diseases-efficacy, side effects, and risk factors for side effects. Semin Arthritis Rheum 1994, 23:310-327. 10.1016/0049-0172(94)90027-2, 8036521.
7. Visser K, van der Heijde DM. Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol 2009, 27:1017-1025.
8. Katchamart W, Trudeau J, Phumethum V, Bombardier C. Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis 2009, 68:1105-1112. 10.1136/ard.2008.099861, 2689526, 19054823.
9. Weinblatt ME, Dixon JA, Falchuk KR. Serious liver disease in a patient receiving methotrexate and leflunomide. Arthritis Rheum 2000, 43:2609-2611. 10.1002/1529-0131(200011)43:11<2609::AID-ANR32>3.0.CO;2-R, 11083289.
10. Kim SU, Choi GH, Han WK, Kim BK, Park JY, Kim do Y, Choi JS, Yang SC, Choi EH, Ahn SH, Han KH, Chon CY. What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea. Liver Int 2010, 30:268-274. 10.1111/j.1478-3231.2009.02172.x, 19929903.
11. Jung KS, Kim SU, Ahn SH, Park YN, Kim do Y, Park JY, Chon CY, Choi EH, Han KH. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011, 53:885-894. 10.1002/hep.24121, 21319193.
12. Kim SU, Seo YS, Cheong JY, Kim MY, Kim JK, Um SH, Cho SW, Paik SK, Lee KS, Han KH, Ahn SH. Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Aliment Pharmacol Ther 2010, 32:498-505. 10.1111/j.1365-2036.2010.04353.x, 20491742.
13. Park SH, Choe JY, Kim SK. Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate. Joint Bone Spine 2010, 77:588-592. 10.1016/j.jbspin.2010.02.024, 20471892.
14. Barbero-Villares A, Mendoza Jiménez-Ridruejo J, Taxonera C, López-Sanromán A, Pajares R, Bermejo F, Pérez-Calle JL, Mendoza JL, Algaba A, Moreno-Otero R, Maté J, Gisbert JP, . Madrid Group for the Study of Inflammatory Bowel Disease ENICMAD Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial. Scand J Gastroenterol 2012, 47:575-579. 10.3109/00365521.2011.647412, 22229701, Madrid Group for the Study of Inflammatory Bowel Disease ENICMAD.
15. Arena U, Stasi C, Mannoni A, Benucci M, Maddali-Bongi S, Cammelli D, Assarat A, Marra F, Pinzani M. Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis. Dig Liver Dis 2012, 44:149-153. 10.1016/j.dld.2011.08.013, 21930442.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
17. Alberti KG, Zimmet P, Shaw J, . IDF Epidemiology Task Force Consensus Group The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062. 10.1016/S0140-6736(05)67402-8, 16182882, IDF Epidemiology Task Force Consensus Group.
18. Beyeler C, Reichen J, Thomann SR, Lauterburg BH, Gerber NJ. Quantitative liver function in patients with rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study. Br J Rheumatol 1997, 36:338-344. 10.1093/rheumatology/36.3.338, 9133966.
19. Ros S, Juanola X, Condom E, Cañas C, Riera J, Guardiola J, Del Blanco J, Rebasa P, Valverde J, Roig-Escofet O. Light and electron microscopic analysis of liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Scand J Rheumatol 2002, 31:330-336. 10.1080/030097402320817040, 12492247.
20. Phillips CA, Cera PJ, Mangan TF, Newman ED. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate. J Rheumatol 1992, 19:229-233.
21. Walker AM, Funch D, Dreyer NA, Tolman KG, Kremer JM, Alarcón GS, Lee RG, Weinblatt ME. Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. Arthritis Rheum 1993, 36:329-335. 10.1002/art.1780360307, 8452577.
22. Mok MY, Ng WL, Yuen MF, Wong RW, Lau CS. Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis. Clin Exp Rheumatol 2000, 18:363-368. 10.1007/s100510070069, 10895374.
23. Behrens F, Koehm M, Burkhardt H. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses. Curr Opin Rheumatol 2011, 23:282-287. 10.1097/BOR.0b013e328344fddb, 21427581.
24. Alcorn N, Saunders S, Madhok R. Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing. Drug Saf 2009, 32:1123-1134. 10.2165/11316650-000000000-00000, 19916579.
25. Ju JH, Kim SI, Lee JH, Lee SI, Yoo WH, Choe JY, Chung SH, Lee J, Lee YH, Lee SS, Yoon HJ, Yoon CH, Kim HY, Park SH. Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis. Arthritis Rheum 2007, 56:2094-2096. 10.1002/art.22666, 17530652.
26. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008, 134:960-974. 10.1053/j.gastro.2008.01.034, 18395077.